| 51 |
25648089 | Genetic Variations of Drug Transporters Can Influence on Drug Response in Patients Treated with Docetaxel Chemotherapy. | 2015 Jul |
4 |
| 52 |
25760729 | DNA methylation of DKK3 modulates docetaxel chemoresistance in human nonsmall cell lung cancer cell. | 2015 Mar |
1 |
| 53 |
25932627 | Validation of a P-Glycoprotein (P-gp) Humanized Mouse Model by Integrating Selective Absolute Quantification of Human MDR1, Mouse Mdr1a and Mdr1b Protein Expressions with In Vivo Functional Analysis for Blood-Brain Barrier Transport. | 2015 |
1 |
| 54 |
25995342 | Antiandrogens Inhibit ABCB1 Efflux and ATPase Activity and Reverse Docetaxel Resistance in Advanced Prostate Cancer. | 2015 Sep 15 |
1 |
| 55 |
26027763 | Serum exosomal P-glycoprotein is a potential marker to diagnose docetaxel resistance and select a taxoid for patients with prostate cancer. | 2015 Sep |
11 |
| 56 |
26057062 | Prostate cancer: Antiandrogens reverse docetaxel resistance via ABCB1 inhibition. | 2015 Jul |
1 |
| 57 |
26154614 | Initial testing (stage 1) of the anti-microtubule agents cabazitaxel and docetaxel, by the pediatric preclinical testing program. | 2015 Nov |
1 |
| 58 |
26506423 | Bis-cyclopropane analog of disorazole C1 is a microtubule-destabilizing agent active in ABCB1-overexpressing human colon cancer cells. | 2015 Dec 1 |
1 |
| 59 |
24219005 | Phase II and pharmacological study of oral docetaxel plus cyclosporin A in anthracycline pre-treated metastatic breast cancer. | 2014 May |
2 |
| 60 |
24883107 | The role of cabazitaxel in the treatment of metastatic castration-resistant prostate cancer. | 2014 Jun |
1 |
| 61 |
21795074 | Combination of docetaxel and vandetanib in docetaxel-sensitive or resistant PC3 cell line. | 2013 Aug |
2 |
| 62 |
22426195 | Increased brain uptake of docetaxel and ketoconazole loaded folate-grafted solid lipid nanoparticles. | 2013 Jan |
4 |
| 63 |
23053273 | Changing the expression vector of multidrug resistance genes is related to neoadjuvant chemotherapy response. | 2013 Jan |
1 |
| 64 |
23364915 | Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death. | 2013 Aug 1 |
2 |
| 65 |
23666532 | Influence of ABCB1 polymorphisms and docetaxel pharmacokinetics on pathological response to neoadjuvant chemotherapy in breast cancer patients. | 2013 Jun |
1 |
| 66 |
23683834 | 20(S)-Protopanaxadiol (PPD) analogues chemosensitize multidrug-resistant cancer cells to clinical anticancer drugs. | 2013 Jul 15 |
2 |
| 67 |
23861346 | Inhibition of ABCB1 expression overcomes acquired docetaxel resistance in prostate cancer. | 2013 Sep |
9 |
| 68 |
23928571 | Coadministration of lapatinib increases exposure to docetaxel but not doxorubicin in the small intestine of mice. | 2013 Oct |
1 |
| 69 |
21505085 | From mouse to man: predictions of human pharmacokinetics of orally administered docetaxel from preclinical studies. | 2012 Mar |
2 |
| 70 |
21720762 | Two different docetaxel resistant MCF-7 sublines exhibited different gene expression pattern. | 2012 Apr |
1 |
| 71 |
22271208 | Prospective evaluation of the drug-metabolizing enzyme polymorphisms and toxicity profile of docetaxel in Korean patients with operable lymph node-positive breast cancer receiving adjuvant chemotherapy. | 2012 May |
1 |
| 72 |
22294184 | The association of statins and taxanes: an efficient combination trigger of cancer cell apoptosis. | 2012 Feb 14 |
2 |
| 73 |
22445862 | Docetaxel and 5-fluorouracil induce human p53 tumor suppressor gene transcription via a short sequence at core promoter element. | 2012 Aug |
1 |
| 74 |
22572929 | FG020326 sensitized multidrug resistant cancer cells to docetaxel-mediated apoptosis via enhancement of caspases activation. | 2012 May 9 |
6 |
| 75 |
23251413 | Docetaxel-resistance in prostate cancer: evaluating associated phenotypic changes and potential for resistance transfer via exosomes. | 2012 |
2 |
| 76 |
23493035 | Different Expression of Extracellular Signal-Regulated Kinases (ERK) 1/2 and Phospho-Erk Proteins in MBA-MB-231 and MCF-7 Cells after Chemotherapy with Doxorubicin or Docetaxel. | 2012 Jan |
2 |
| 77 |
21262849 | Ixabepilone, a novel microtubule-targeting agent for breast cancer, is a substrate for P-glycoprotein (P-gp/MDR1/ABCB1) but not breast cancer resistance protein (BCRP/ABCG2). | 2011 May |
1 |
| 78 |
21448449 | Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancer. | 2011 Mar 10 |
4 |
| 79 |
21468756 | The effects of CYP3A4, CYP3A5, ABCB1, ABCC2, ABCG2 and SLCO1B3 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of docetaxel in nasopharyngeal carcinoma patients. | 2011 Jun |
2 |
| 80 |
21695098 | Clinical development of cabazitaxel for the treatment of castration-resistant prostate cancer. | 2011 |
1 |
| 81 |
22011009 | Resveratrol enhances the cytotoxic profile of docetaxel and doxorubicin in solid tumour cell lines in vitro. | 2011 Dec |
1 |
| 82 |
20041327 | PXR-mediated induction of P-glycoprotein by anticancer drugs in a human colon adenocarcinoma-derived cell line. | 2010 Sep |
2 |
| 83 |
20628376 | Effect of ABCB1 C3435T polymorphism on docetaxel pharmacokinetics according to menopausal status in breast cancer patients. | 2010 Aug 10 |
3 |
| 84 |
20829196 | I-387, a novel antimitotic indole, displays a potent in vitro and in vivo antitumor activity with less neurotoxicity. | 2010 Nov |
2 |
| 85 |
18812689 | MDR1 single nucleotide polymorphism G2677T/A and haplotype are correlated with response to docetaxel-cisplatin chemotherapy in patients with non-small-cell lung cancer. | 2009 |
3 |
| 86 |
19262372 | Inhibition of P-glycoprotein-mediated docetaxel efflux sensitizes ovarian cancer cells to concomitant docetaxel and SN-38 exposure. | 2009 Apr |
4 |
| 87 |
19332043 | Side effects after docetaxel treatment in Taiwanese breast cancer patients with CYP3A4, CYP3A5, and ABCB1 gene polymorphisms. | 2009 Jun 27 |
1 |
| 88 |
17876342 | PXR, CAR and HNF4alpha genotypes and their association with pharmacokinetics and pharmacodynamics of docetaxel and doxorubicin in Asian patients. | 2008 Apr |
1 |
| 89 |
18063021 | Expression and activity of taxane-metabolizing enzymes in ovarian tumors. | 2008 Feb |
1 |
| 90 |
18281755 | [Prediction of response to docetaxel in breast cancer]. | 2008 Feb |
1 |
| 91 |
18628469 | ABCB1 genetic variation influences the toxicity and clinical outcome of patients with androgen-independent prostate cancer treated with docetaxel. | 2008 Jul 15 |
6 |
| 92 |
19001875 | Hypermethylation of the ABCB1 downstream gene promoter accompanies ABCB1 gene amplification and increased expression in docetaxel-resistant MCF-7 breast tumor cells. | 2008 Sep |
4 |
| 93 |
17256132 | Influence of ketoconazole on the fecal and urinary disposition of docetaxel. | 2007 Sep |
2 |
| 94 |
17683514 | Pilot study of MDR1 gene transfer into hematopoietic stem cells and chemoprotection in metastatic breast cancer patients. | 2007 Oct |
2 |
| 95 |
17907967 | Retroviral integration site analysis and the fate of transduced clones in an MDR1 gene therapy protocol targeting metastatic breast cancer. | 2007 Oct |
2 |
| 96 |
17912240 | ZD6474 reverses multidrug resistance by directly inhibiting the function of P-glycoprotein. | 2007 Oct 8 |
2 |
| 97 |
16518057 | Gene therapy for breast cancer. --Review of clinical gene therapy trials for breast cancer and MDR1 gene therapy trial in Cancer Institute Hospital. | 2006 |
1 |
| 98 |
16529050 | [Gene therapy for relapsed breast cancer]. | 2006 Mar |
1 |
| 99 |
16805818 | Predictive factors for response to docetaxel in human breast cancers. | 2006 Sep |
1 |
| 100 |
17020985 | Pharmacogenetic screening of CYP3A and ABCB1 in relation to population pharmacokinetics of docetaxel. | 2006 Oct 1 |
5 |